Chalain le Comtal, France

Jean-Christophe Antoine

This inventor holds 7 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Centre Hospitalier Universitaire De Saint-Étienne, Centre National De La Recherche Scientifique. Active years: 2007-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Christophe Antoine. Retrieved from https://idiyas.com/inventor/jean-christophe-antoine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 57.1

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Chalin le Comtal, FR (2007)
  • Chalain le Comtal, FR (2008 - 2018)
  • Saint-etienne, FR (2017 - 2020)

Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Christophe Antoine

Introduction

Jean-Christophe Antoine, an accomplished inventor based in Chalain le Comtal, France, has made significant strides in the field of medical science. With a portfolio of seven patents, Antoine has created innovations that hold immense potential for diagnosing and treating serious health conditions.

Latest Patents

Among his latest patents are groundbreaking discoveries in the understanding of nerve-related disorders. His invention on "Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies" focuses on the diagnosis and treatment of acquired sensory neuronopathies (SNN). This invention highlights the importance of specific receptors as markers for these complex disorders. Another notable patent is centered around the "Human ULIP/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes." This innovation includes a purified polypeptide, termed ULIP6, which is crucial for diagnosing paraneoplastic neurological syndromes and early cancerous tumor developments, along with its specific nucleic acid sequences and antibodies.

Career Highlights

Jean-Christophe Antoine has gained valuable experience working with prestigious institutions, including the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Centre National de la Recherche Scientifique (CNRS). His affiliation with these research organizations has enabled him to advance his research and contribute to groundbreaking medical innovations.

Collaborations

Throughout his career, Antoine has collaborated with esteemed professionals such as Marie-Françoise Belin and Jérôme Honnorat. These partnerships have enriched his research through shared knowledge and expertise, which is essential in the ever-evolving field of medical science.

Conclusion

Jean-Christophe Antoine continues to be a pivotal figure in medical innovation, demonstrating a commitment to improving diagnostic and treatment methods for serious health conditions. His contributions through patents not only enhance the understanding of sensory neuronopathies and related disorders but also represent the collaborative spirit of modern scientific research. As he pushes the boundaries of medical science, his work stands as a testament to the power of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…